Zosano Pharma Corp (ZSAN) has 42 open-market insider trades by 19 insiders since 2015. The most active filer is M. James Barrett, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| M. James Barrett | 10% Owner | — | 8 | $4.8M | 2017-02-13 |
| NEA 12 Gp, LLC via M. James Barrett | 10% Owner | — | 2 | $2.2M | 2017-02-13 |
| Gerald J. Kazma | 10% Owner | — | 1 | $1.4M | 2018-02-27 |
| John Peter Walker | CEOPres | — | 3 | $585K | 2020-06-25 |
| Konstantinos Alataris | CEOPres | — | 2 | $336K | 2017-03-20 |
| Realty L. P. BioMed | 10% | — | 1 | $292K | 2015-01-30 |
| Ryan D. Drant | 10% | — | 1 | $258K | 2015-01-30 |
| Georgia Erbez | CFO | — | 2 | $153K | 2017-05-25 |
| Kenneth Greathouse | Dir | — | 4 | $130K | 2021-11-23 |
| Forest Baskett | 10% Owner | — | 2 | $52K | 2016-08-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steven Lo | CEO | Sell | $314 | 2022-06-06 |
| Christine Matthews | CFO | Sell | $58 | 2022-06-06 |
| Christine Matthews | CFO | Sell | $2K | 2022-03-31 |
| Donald J. Kellerman | VP & Clinical Dev & Med Affairs | Sell | $841 | 2022-03-31 |
| Steven Lo | CEO | Sell | $5K | 2022-03-31 |
| Kenneth Greathouse | Director | Sell | $6K | 2021-11-23 |
Companies that share insiders with ZSAN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Steven Lo | CEO | Sell | $11K | 2021-06-04 |
| Hayley Lewis | — | Sell | $1K | 2021-06-04 |
| John Peter Walker | CEO & President | Buy | $350K | 2019-04-11 |
| Gerald J. Kazma | 10% Owner | Sell | $1.4M | 2018-02-26 |
| Kenneth Greathouse | Director | Buy | $34K | 2017-12-06 |
| Kenneth Greathouse | Director | Buy | $59K | 2017-11-30 |
| Kenneth Greathouse | Director | Buy | $31K | 2017-11-14 |
| Georgia Erbez | CFO | Buy | $90K | 2017-05-25 |
| John Peter Walker | CEO | Buy | $151K | 2017-05-24 |